Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Exp Neurol
    August 2022
  1. GOMES P, Tzouanou F, Skolariki K, Iakovou AV, et al
    Extracellular vesicles and Alzheimer's disease in the novel era of Precision Medicine: Implications for disease progression, diagnosis and treatment.
    Exp Neurol. 2022 Aug 8:114183. doi: 10.1016/j.expneurol.2022.114183.
    >> Share

    June 2022
  2. HUSSEIN A, Tielemans A, Baxter MG, Benson DL, et al
    Cognitive deficits and altered cholinergic innervation in young adult male mice carrying a Parkinson's disease Lrrk2(G2019S) knockin mutation.
    Exp Neurol. 2022 Jun 19:114145. doi: 10.1016/j.expneurol.2022.114145.
    >> Share

    December 2021
  3. SPOLETI E, Krashia P, La Barbera L, Nobili A, et al
    Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model.
    Exp Neurol. 2021 Dec 30:113969. doi: 10.1016/j.expneurol.2021.113969.
    >> Share

    October 2021
  4. PENG YG, Cai PJ, Hu JH, Jiang JX, et al
    Altered corticostriatal synchronization associated with compulsive-like behavior in APP/PS1 mice.
    Exp Neurol. 2021;344:113805.
    >> Share

    September 2021
  5. WANG J, Liu B, Xu Y, Luan H, et al
    Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer's disease via inhibiting gliosis.
    Exp Neurol. 2021;347:113870.
    >> Share

    August 2021
  6. LI ZY, Chen LH, Zhao XY, Chen H, et al
    Clemastine attenuates AD-like pathology in an AD model mouse via enhancing mTOR-mediated autophagy.
    Exp Neurol. 2021;342:113742.
    >> Share

    May 2021
  7. ISLA AG, Balleza-Tapia H, Fisahn A
    Efficacy of preclinical pharmacological interventions against alterations of neuronal network oscillations in Alzheimer's disease: A systematic review.
    Exp Neurol. 2021 May 14:113743. doi: 10.1016/j.expneurol.2021.113743.
    >> Share

  8. ANNADURAI N, De Sanctis JB, Hajduch M, Das V, et al
    Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
    Exp Neurol. 2021 May 11:113756. doi: 10.1016/j.expneurol.2021.113756.
    >> Share

    March 2021
  9. NEVES AF, Camargo C, Premer C, Hare JM, et al
    Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease.
    Exp Neurol. 2021 Mar 20:113706. doi: 10.1016/j.expneurol.2021.113706.
    >> Share

  10. MANSOUR HM, Fawzy HM, El-Khatib AS, Khattab MM, et al
    Lapatinib ditosylate rescues memory impairment in D-galactose/ovariectomized rats: Potential repositioning of an anti-cancer drug for the treatment of Alzheimer's disease.
    Exp Neurol. 2021 Mar 13:113697. doi: 10.1016/j.expneurol.2021.113697.
    >> Share

    January 2021
  11. NAKANISHI K, Sakakima H, Norimatsu K, Otsuka S, et al
    Effect of low-intensity motor balance and coordination exercise on cognitive functions, hippocampal Abeta deposition, neuronal loss, neuroinflammation, and oxidative stress in a mouse model of Alzheimer's disease.
    Exp Neurol. 2021;337:113590.
    >> Share

  12. MCKNIGHT I, Hart C, Park IH, Shim JW, et al
    Genes causing congenital hydrocephalus: Their chromosomal characteristics of telomere proximity and DNA compositions.
    Exp Neurol. 2021;335:113523.
    >> Share

    December 2020
  13. TANAKA T, Hirai S, Hosokawa M, Saito T, et al
    Early-life stress induces the development of Alzheimer's disease pathology via angiopathy.
    Exp Neurol. 2020 Dec 9:113552. doi: 10.1016/j.expneurol.2020.113552.
    >> Share

  14. CHEN HC, Cao JX, Cai YT, Du HL, et al
    Interaction of human IAPP and Abeta1-42 aggravated the AD-related pathology and impaired the cognition in mice.
    Exp Neurol. 2020;334:113490.
    >> Share

    May 2020
  15. CHEN C, Xu D, Zhang ZH, Jia SZ, et al
    Cognitive improvement and synaptic deficit attenuation by a multifunctional carbazole-based cyanine in AD mice model through regulation of Ca(2+)/CaMKII/CREB signaling pathway.
    Exp Neurol. 2020;327:113210.
    >> Share

    April 2020
  16. WEIDLING IW, Swerdlow RH
    Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis.
    Exp Neurol. 2020;330:113321.
    >> Share

    March 2020
  17. ECKERT GP, Eckert SH, Eckmann J, Hagl S, et al
    Olesoxime improves cerebral mitochondrial dysfunction and enhances Abeta levels in preclinical models of Alzheimer's disease.
    Exp Neurol. 2020 Mar 18:113286. doi: 10.1016/j.expneurol.2020.113286.
    >> Share

    February 2020
  18. VICENTE MC, Humphrey CM, Gargaglioni LH, Ostrowski TD, et al
    Decreased excitability of locus coeruleus neurons during hypercapnia is exaggerated in the streptozotocin-model of Alzheimer's disease.
    Exp Neurol. 2020 Feb 20:113250. doi: 10.1016/j.expneurol.2020.113250.
    >> Share

  19. GREWAL R, Reutzel M, Dilberger B, Hein H, et al
    Purified oleocanthal and ligstroside protect against mitochondrial dysfunction in models of early Alzheimer's disease and brain ageing.
    Exp Neurol. 2020 Feb 18:113248. doi: 10.1016/j.expneurol.2020.113248.
    >> Share

  20. LIU B, Liu J, Wang JG, Liu CL, et al
    AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
    Exp Neurol. 2020 Feb 15:113249. doi: 10.1016/j.expneurol.2020.113249.
    >> Share

    November 2019
  21. WU GD, Li ZH, Li X, Zheng T, et al
    microRNA-592 blockade inhibits oxidative stress injury in Alzheimer's disease astrocytes via the KIAA0319-mediated Keap1/Nrf2/ARE signaling pathway.
    Exp Neurol. 2019 Nov 21:113128. doi: 10.1016/j.expneurol.2019.113128.
    >> Share

  22. MUNSTER Y, Keyvani K, Herring A
    Inhibition of excessive kallikrein-8 improves neuroplasticity in Alzheimer's disease mouse model.
    Exp Neurol. 2019 Nov 14:113115. doi: 10.1016/j.expneurol.2019.113115.
    >> Share

  23. BOESE AC, Hamblin MH, Lee JP
    Neural stem cell therapy for neurovascular injury in Alzheimer's disease.
    Exp Neurol. 2019 Nov 12:113112. doi: 10.1016/j.expneurol.2019.113112.
    >> Share

    August 2019
  24. GRILLO CA, Woodruff JL, Macht VA, Reagan LP, et al
    Insulin resistance and hippocampal dysfunction: Disentangling peripheral and brain causes from consequences.
    Exp Neurol. 2019;318:71-77.
    >> Share

    July 2019
  25. NUZZO T, Feligioni M, Cristino L, Pagano I, et al
    Free d-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking d-aspartate oxidase activity.
    Exp Neurol. 2019;317:51-65.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016